Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kurralta Park
Clinical trial register · Australia

Clinical Trials in Kurralta Park, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC6 AstraZeneca6 Eli Lilly and Company4 Pfizer4 Exelixis3
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Kurralta Park

51 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Verastem, Inc.
Phase 2
150
Macquarie Park, Waratah, Hyde Park, South Brisbane, Kurralta Park, Hobart
2026-07-28
Recruiting
BeOne Medicines
Phase 1
118
Concord, Kogarah, Kurralta Park, Geelong, Heidelberg, Nedlands
2026-06-23
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
NCT07644559Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
DrugsVS-7375·Cetuximab
Verastem, Inc.
Phase 2
185
Sydney, Waratah, Hyde Park, Kurralta Park, South Brisbane
2026-06-16
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-22
Recruiting
AstraZeneca
Phase 3
670
Darlinghurst, Kurralta Park, Melbourne, Murdoch
2026-05-04
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Heidelberg, Kurralta Park, Melbourne, Wahroonga, Woolloongabba
2025-12-19
Recruiting
Pfizer
Phase 2/3
982
Nowra, Westmead, Kurralta Park, Hobart, St Albans
2025-10-03
Recruiting
Pfizer
Phase 3
1,000
Orange, Wahroonga, South Brisbane, Kurralta Park, Nedlands
2025-09-28
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Waratah, Kurralta Park, Heidelberg, Melbourne, Murdoch
2025-09-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Heidelberg, Kurralta Park, Melbourne, Murdoch, Woolloongabba
2025-09-02
Recruiting
Pfizer
Phase 3
400
Kurralta Park, Melbourne, St Albans
2025-08-05
Recruiting
Sanofi
Phase 2
99
Brisbane, Kurralta Park, Footscray
2025-06-03
Active, closed
Sanofi
Phase 2
204
Kurralta Park, Richmond
2025-03-28
Recruiting
Eli Lilly and Company
Phase 3
700
Auchenflower, Birtinya, Heidelberg, Kurralta Park, North Tamworth, Perth, Shepparton, Traralgon
2025-03-27
Active, closed
Fusion Pharmaceuticals Inc.
Phase 2
85
Macquarie Park, Woolloongabba, Kurralta Park, Melbourne
2025-02-26
Active, closed
Gilead Sciences
Phase 2
39
Sydney, Kurralta Park, Clayton, Melbourne
2025-02-18
Recruiting
BioNTech SE
Phase 3
621
Waratah, Wollongong, Cairns, Kurralta Park, Woodville, Frankston, Heidelberg, St Albans
2025-02-03
Recruiting
BioNTech SE
Phase 2/3
1,580
Adelaide, Bedford Park, Cairns, Dubbo, Frankston, Joondalup, Kurralta Park, Melbourne
2025-01-07
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Adelaide, Bankstown, Box Hill, Coffs Harbour, Hobart, Kurralta Park, Traralgon, Waratah
2025-01-03
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bedford Park, Herston, Kurralta Park, Melbourne, Perth, Woolloongabba, QLD
2024-07-18
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
NCT06242470Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck
MacroGenics
Phase 1
250
Auchenflower, Kurralta Park, Heidelberg
2024-03-06
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Heidelberg, Kurralta Park
2024-03-05
Active, closed
AbbVie
Observational
1,200
Blacktown, Macquarie University, South Brisbane, Kurralta Park, Woodville South, Clayton, Melbourne
2024-02-19
Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT06244771Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor
Frontier Medicines Corporation
Phase 1/2
403
Macquarie Park, Southport, Kurralta Park, North Adelaide, Box Hill, Nedlands
2024-02-12
Active, closed
AstraZeneca
Phase 3
1,898
Chermside, Darlinghurst, Hyde Park, Kurralta Park, Melbourne, South Brisbane
2023-11-21
Recruiting
BeOne Medicines
Phase 1
337
Miranda, North Ryde, Kurralta Park, Nedlands
2023-09-21
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05818683Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
DrugsJNJ-101556143·Lutetium Lu-177 vipivotide tetraxetan·Pasritamig·Cabazitaxel
Janssen Research & Development, LLC
Phase 1
300
Kurralta Park, Macquarie University, Melbourne, Woolloongabba
2023-04-26
Active, closed
Hoffmann-La Roche
Phase 2
204
Macquarie Park, Adelaide, Kurralta Park
2023-04-13
Active, closed
Pfizer
Phase 3
624
Coffs Harbour, Birtinya, Woolloongabba, Kurralta Park, Hobart, Brighton, Geelong, Malvern
2023-03-03
Active, closed
Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
NCT05614258Advanced/Metastatic Solid Tumors
Adagene Inc
Phase 1
14
Kurralta Park, Clayton
2023-02-13
Active, closed
Silence Therapeutics plc
Phase 1/2
69
Benowa, Hobart, Kurralta Park, Melbourne, Nedlands, Richmond
2023-01-26
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bedford Park, Footscray, Kurralta Park, Liverpool, Newcastle, Southport, Sydney, Westmead
2022-08-17
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Garran, Tweed Heads, Kurralta Park, Heidelberg, Murdoch
2022-08-08
Active, closed
Eli Lilly and Company
Phase 3
874
Darlinghurst, Woolloongabba, Kurralta Park, Box Hill, Melbourne
2021-10-04
Active, closed
Immunome, Inc.
Phase 2/3
198
Camperdown, Woolloongabba, Kurralta Park, Melbourne
2021-09-01
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Bendigo, Concord, Fitzroy, Gosford, Kurralta Park, Melbourne, St Albans, Sydney
2021-03-18
Active, closed
Bayer
Phase 3
402
Kurralta Park
2020-10-20
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Birtinya, Darlinghurst, Herston, Hobart, Kurralta Park, Liverpool, Melbourne, Murdoch
2020-09-23
Active, closed
AstraZeneca
Phase 3
818
Adelaide, Ballarat, Birtinya, Box Hill, Concord, Kurralta Park, North Sydney, Orange
2020-04-16
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Darlinghurst, Liverpool, South Brisbane, Kurralta Park, Heidelberg
2019-03-20
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Albury, Randwick, Woolloongabba, Kurralta Park, Melbourne
2019-02-08
Active, closed
AstraZeneca
Phase 3
895
Box Hill, Darlinghurst, Greenslopes, Herston, Kingswood, Kurralta Park, St Albans, Waratah
2018-10-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
North Sydney, Westmead, Cairns, Southport, Woolloongabba, Adelaide, Kurralta Park, Melbourne
2018-09-12
Active, closed
Exelixis
Phase 3
837
Camperdown, Darlinghurst, Kingswood, Kogarah, Westmead, Greenslopes, Kurralta Park, Box Hill
2018-06-10
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
St Leonards, Chermside, Kurralta Park
2017-09-22
Active, closed
AstraZeneca
Phase 3
682
Bedford Park, Camperdown, Darlinghurst, Heidelberg, Kogarah, Kurralta Park, Woolloongabba
2015-10-21
Active, closed
Exelixis
Phase 4
247
St Leonards, Herston, Kurralta Park, Parkville
2015-02-25
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Darlinghurst, Liverpool, Waratah, South Brisbane, Adelaide, Kurralta Park, Clayton, East Melbourne
2014-11
Active, closed
Eli Lilly and Company
Phase 3
669
South Brisbane, Southport, Kurralta Park, East Bentleigh, Subiaco
2014-07-22
Active, closed
AstraZeneca
Phase 3
510
Camperdown, Chermside, Darlinghurst, Fitzroy, Kogarah, Kurralta Park, Malvern, Wendouree
2013-09-25
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/kurralta-park

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Kurralta Park.

How many clinical trials are recruiting in Kurralta Park?

23 of the 51 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 28 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kurralta Park), 51 studies
PhaseStudiesRecruitingShare
Phase 3241047.1%
Phase 211521.6%
Phase 17413.7%
Phase 2/3539.8%
Phase 1/2213.9%
Observational102%
Phase 4102%

Most active sponsors

Lead sponsors with the most studies (Kurralta Park)
Lead sponsorStudiesRecruiting
AstraZeneca61
Janssen Research & Development, LLC65
Eli Lilly and Company41
Pfizer43
Exelixis30
BeOne Medicines22
BioNTech SE22
Hoffmann-La Roche20
Sanofi21
Verastem, Inc.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.